Skip to main content
HR 4619 116th Congress House Health Business records Civil actions and liability Government information and archives Government trust funds Health care costs and insurance Inflation and prices Medicare Prescription drugs

Pharmaceutical REPAI Act

Introduced: October 8, 2019 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 9, 2019
Referred to the Subcommittee on Health.
Oct 8, 2019
Referred to the Subcommittee on Health.
Oct 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 8, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act

This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.

What's happening now October 9, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4